ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Hanyang, Seoul

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Coronavirus Infections
Human Influenza
Communicable Diseases
Pneumonia
Post-Acute COVID-19 Syndrome
Respiratory Distress Syndrome

COVID-19 trials near Hanyang, Seoul, KOR:

Immunogenicity and Safety of AdCLD-CoV19-1 OMI As a Booster: a COVID-19 Preventive Vaccine in Healthy Volunteers (COVID-19)

The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/dose/Vial) administered as a booster in healthy adults aged 19 years old a...

Active, not recruiting
COVID-19
Vaccines
Biological: Comirnaty Bivalent 0.1mg/mL (tozinameran and riltozinameran)
Biological: AdCLD-CoV19-1 OMI

Phase 3

Cellid

Seoul, Korea, Republic of and 16 other locations

legal age for adult in each country) with confirmed mild or moderate COVID-19 tested positive with a real time reverse transcriptio...

Enrolling
COVID-19
Drug: ES16001 80 mg
Drug: ES16001 40 mg

Phase 2, Phase 3

Genencell

Seoul, Korea, Republic of and 2 other locations

Parallel-treatment Group, Adaptive Design, Multi-center, Phase 2b/3 Trial to Evaluate Efficacy and Safety of NuSepin® Intravenous Infusion in COVID...

Enrolling
COVID-19 Pneumonia
Drug: Placebo
Drug: NuSepin® 0.2 mg/kg

Phase 2, Phase 3

Shaperon

Incheon, Namdong-gu, Korea, Republic of

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Seoul, Gyeonggi-do, Korea, Republic of and 66 other locations

The purpose of the study is to evaluate the immunogenicity, reactogenicity, and safety of mRNA-1083 in adults 50 years of age and older in participat...

Enrolling
COVID-19
Influenza
Biological: Licensed Influenza Vaccine
Biological: mRNA-1083

Phase 3

Moderna
Moderna

Seoul, Korea, Republic of and 44 other locations

Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...

Enrolling
Coronavirus Disease (COVID-19)
Drug: Placebo
Drug: Molnupiravir

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Seoul, Korea, Republic of and 127 other locations

This study is to evaluate the safety, reactogenicity, and immunogenicity of the QTP104 vaccine against SARS-CoV-2 infection in healthy adults.

Active, not recruiting
COVID-19
SARS-CoV-2
Biological: QTP104 1ug
Biological: QTP104 5ug

Phase 1

Quratis

Seoul, Korea, Republic of and 1 other location

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting
Early Alzheimer's Disease
Drug: Placebo
Drug: Lecanemab

Phase 3

Eisai
Eisai

Seoul, Korea, Republic of and 246 other locations

The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...

Enrolling
Viral Lung Infection and Acute Respiratory Failure
Drug: Tozorakimab
Drug: Placebo

Phase 3

AstraZeneca
AstraZeneca

Seoul, Korea, Republic of and 441 other locations

treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

Phase 3

AbbVie
AbbVie

Seoul, Seoul Teugbyeolsi, Korea, Republic of and 431 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems